Pink Sheet Pharma Regulatory Podcast: FDA Panels Deliver Shocking Verdicts On Twirla, Makena

Citeline Podcasts - A podcast by Citeline

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Pink Sheet reporters discuss the implications from recent US FDA advisory committee meetings for Agile's contraceptive patch Twirla and AMAG’s preterm birth drug Makena.

Visit the podcast's native language site